Latest news

Insights

Why Data Is Becoming Pharma’s Most Valuable Asset

Pharma's:Executive Summary For decades, pharmaceutical companies have built competitive advantage around scientific expertise, intellectual property, manufacturing capabilities, commercial reach, and...
Commercial

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

PTC Therapeutics has agreed to acquire Sangamo Therapeutics’ ST-920 Fabry disease gene therapy program, gaining control of a treatment...
Commercial

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

While the FDA considers whether to approve Takeda and Protagonist Therapeutics' rusfertide, Zealand Pharma has monetized its remaining economic...
Clinical

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

Taiho Pharmaceutical and Cullinan Therapeutics announced that their investigational EGFR inhibitor zipalertinib, combined with platinum-based chemotherapy, met the primary...
Commercial

Eli Lilly Files Six Lawsuits Over Sales of Unapproved Retatrutide

Eli Lilly has filed six new lawsuits in the...
Insights

Top 10 Strategic Priorities for Pharma CEOs in 2027

Executive Summary The pharmaceutical industry is entering 2027 with a...
Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed Chief Executive Officer Natalie Holles, shifting its focus toward ocular...
Insights

Top 10 Trends Reshaping Pharmaceutical Sales

Executive Summary Pharmaceutical sales are undergoing one of the most significant transformations in decades. The traditional commercial model—built around face-to-face...
Clinical

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics has reported positive topline results from the phase 3 IZAR-1 trial evaluating its lead nanobody candidate, sonelokimab,...
Commercial

Jazz Pharmaceuticals to Acquire Actio for Up to $1.32 Billion to Add KCNT1 Epilepsy Therapy

Jazz Pharmaceuticals has agreed to acquire Actio Biosciences in...
Insights

Top 10 Technologies Accelerating Drug Discovery

Executive Summary Drug discovery is undergoing one of the most...
Regulatory

FDA Advisory Panel to Review Grail’s Galleri Multi-Cancer Blood Test in September

Grail said the U.S. Food and Drug Administration (FDA) plans to convene a meeting of outside experts on Sept....
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting therapy S-oxprenolol, giving the company full control over the program...
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational restructuring as it concentrates its resources on the development of...
Commercial

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

PTC Therapeutics has agreed to acquire Sangamo Therapeutics’ ST-920...
Editorial Team -

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

Regulatory

Commercial

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

PTC Therapeutics has agreed to acquire Sangamo Therapeutics’ ST-920...
Commercial

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

While the FDA considers whether to approve Takeda and...
Clinical

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

Taiho Pharmaceutical and Cullinan Therapeutics announced that their investigational...
Insights

Reinventing the Pharmaceutical Commercial Model

Executive Summary The pharmaceutical commercial model is entering a period...

Research & Development

Market Access

Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Why Data Is Becoming Pharma’s Most Valuable Asset

Pharma's:Executive Summary For decades, pharmaceutical companies have built competitive advantage...
Editorial Team -
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Editorial Team -